Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

Show other versions (1)

<h4>Background</h4> A history of spontaneous preterm birth (sPTB) is a significant risk factor for recurrence. Intra-muscular-7α-hydroxyprogesterone caproate (17P) has been the preventive treatment of choice until the recent “Prolong study” that reported no benefit. <h4>Objective&l...

Full description

Bibliographic Details
Main Authors:	Gal Cohen, Maya Shavit, Netanella Miller, Rimon Moran, Yael Yagur, Omer Weitzner, Michal Ovadia, Hanoch Schreiber, Gil Shechter-Maor, Tal Biron-Shental
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098016/?tool=EBI

Similar Items

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
by: Gal Cohen, et al.
Published: (2022-01-01)

Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial.
by: Tan, P.C., et al.
Published: (2011)

HMGB1-RAGE signaling pathway in pPROM
by: Huan Yan, et al.
Published: (2018-04-01)

Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
by: Stephanie M. Garcia, et al.
Published: (2021-07-01)

17-α Hydroxyprogesterone Caproate Immunology, a Special Focus on Preterm Labor, Preeclampsia, and COVID-19
by: Rasha A. Al-Lami
Published: (2022-08-01)

Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020-07-01)

Understanding barriers to utilization of 17-hydroxyprogesterone caproate and other interventions to prevent preterm birth in Fresno County, California
by: Subhashini Ladella, et al.
Published: (2021-08-01)

Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
by: Kim A. Boggess, et al.
Published: (2018-04-01)

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial
by: Combs C Andrew, et al.
Published: (2011-12-01)

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
by: Joan T. Price, et al.
Published: (2019-02-01)

Vaginal Sampling of Amniotic Fluid in pPROM: A New Technique for Early Detection of Subclinical Chorioamnionitis?
by: Salvatore Gizzo, et al.
Published: (2015-02-01)

Discontinuation of long-established Hydroxyprogesterone Caproate; call for awareness and drug-substitutes: A Letter to the Editor
by: Muhammad Affan, et al.
Published: (2023-10-01)

A Comparison between the Effects of Vaginal Suppository Progesterone vs. the Injection of 17-Alpha Hydroxyprogesterone Caproate on the Duration of Latent Phase After Controlled Threatened Preterm Labor
by: Fatemeh Mirzaei, et al.
Published: (2018-03-01)

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
by: Vidaeff AC, et al.
Published: (2013-07-01)

Effectiveness of 17-Alpha-Hydroxyprogesterone in the Prevention of Preterm Labour
by: Uzma Urooj, et al.
Published: (2023-03-01)

LABOUR TERMINATION AND PERINATAL OUTCOME IN PREGNANT WOMEN WITH PLACENTA ABRUPTION WITH PPROM AND PROM
by: Ranko Kutlesic, et al.
Published: (2007-10-01)

Production and Scale-Up of a Monoclonal Antibody Against 17-Hydroxyprogesterone
by: Chua, Gek Kee, et al.
Published: (2013)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
by: Claudia Teti, et al.
Published: (2023-05-01)

Influence of sample quality on phenylalanine and 17-hydroxyprogesterone levels in neonatal screening
by: Lesley del Río Fabre, et al.

Analysis of the Influencing Factors of 17-Hydroxyprogesterone Level and the Correlation between 17-Hydroxyprogesterone Level and the Clinical Parameters Related to Adrenal Cortical Function in Very-Low-Birth-Weight Infants
by: Chang Dae Kum, et al.
Published: (2019-02-01)

17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
by: Saeed Baradwan, et al.
Published: (2021-11-01)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
by: Tomoyo Itonaga, et al.
Published: (2022-01-01)

Solubility, Thermodynamic Parameters, and Dissolution Properties of 17‑α Hydroxyprogesterone in 13 Pure Solvents
by: Qi Zhao, et al.
Published: (2024-03-01)

C-Reactive Protein and Matrix Metalloproteinase-7 in Preterm Premature Rupture of Membranes (PPROM) and Premature Rupture of Membranes (PROM)
by: Rajuddin Rajuddin, et al.
Published: (2022-07-01)

Cortisol, progesterone, 17α-hydroxyprogesterone, and TSH responses in dogs injected with low-dose lipopolysaccharide
by: Nicole L.B. Corder-Ramos, et al.
Published: (2019-08-01)

Evaluation of scrotal pigmentation in infants with spectroscopic method and its correlation with 17-hydroxyprogesterone blood levels
by: Abdurrahman Erdem Basaran, et al.
Published: (2020-03-01)

Neonatal screening for congenital adrenal hyperplasia: considerations regarding the transient rise of the 17-hydroxyprogesterone - doi:10.5020/18061230.2006.p203
by: Crésio Alves, et al.
Published: (2012-01-01)

Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
by: Charmandari, E, et al.
Published: (2001)

Determination of Variation in Neonatal Serum 17 Hydroxyprogesterone Levels in Relation with Gestational Age & Low Birth Weight
by: Ammar ul Hassan, Zujaja Hina Haroon, Muhammad Anwar, Muhammad Younas, Muhammad Usman Munir, Sobia Irum Kirmani
Published: (2023-09-01)

Vacuum-Assisted Delivery Complication Rates Based on Ultrasound-Estimated Fetal Weight
by: Hanoch Schreiber, et al.
Published: (2022-06-01)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
by: Mark R de Hora, et al.
Published: (2020-01-01)

Kadar Hormon 17α-Hydroxyprogesterone (17-Ohp) Serum pada Pasien Pria dengan Akne Vulgaris Sedang-Berat dan Tanpa Akne Vulgaris
by: Ellenita Soebakti, et al.
Published: (2018-05-01)

Gender-Specific Independent and Combined Effects of the Progesterone and 17-Hydroxyprogesterone on Metabolic Syndrome: From the Henan Rural Cohort Study
by: Wang M, et al.
Published: (2021-10-01)

P17
by: O. Kokorev, et al.
Published: (2015-11-01)

Early Neurodevelopmental Outcomes after Previable Preterm Prelabour Rupture of Membranes (pPPROM)
by: Christy L. Pylypjuk, et al.
Published: (2022-01-01)

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
by: Viktoria Stachanow, et al.
Published: (2023-03-01)

Regulation of 17α-Hydroxyprogesterone Production during Induced Oocyte Maturation and Ovulation in Amur Sturgeon (<i>Acipenser schrenckii</i>)
by: Yuya Hasegawa, et al.
Published: (2022-01-01)

17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth
by: Manali Patki, et al.
Published: (2019-07-01)

A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
by: Özge Besci, et al.
Published: (2022-06-01)

17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials
by: Abdulaali R. Almutairi, et al.
Published: (2021-12-01)